FDA withdraws Covid antibody treatment Evusheld because it’s not effective against 93% of subvariants
Evusheld (tixagevimab and cilgavimab) injection, a new COVID-19 treatment that people can take before becoming symptomatic. (Chris Sweda/Chicago Tribune/Tribune News Service via Getty Images) Chris Sweda | Tribune News Service…